Cargando…
Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021
BACKGROUND: Nondiabetic kidney disease (NDKD), which is prevalent among patients with diabetes mellitus (DM), is considerably different from diabetic kidney disease (DKD) in terms of the pathological features, treatment strategy and prognosis. Although renal biopsy is the current gold-standard diagn...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248150/ https://www.ncbi.nlm.nih.gov/pubmed/35773653 http://dx.doi.org/10.1186/s12902-022-01082-8 |
_version_ | 1784739310665203712 |
---|---|
author | Zeng, Yong-qin Yang, Yu-xing Guan, Cheng-jing Guo, Zi-wei Li, Bo Yu, Hai-yan Chen, Rui-xue Tang, Ying-qian Yan, Rui |
author_facet | Zeng, Yong-qin Yang, Yu-xing Guan, Cheng-jing Guo, Zi-wei Li, Bo Yu, Hai-yan Chen, Rui-xue Tang, Ying-qian Yan, Rui |
author_sort | Zeng, Yong-qin |
collection | PubMed |
description | BACKGROUND: Nondiabetic kidney disease (NDKD), which is prevalent among patients with diabetes mellitus (DM), is considerably different from diabetic kidney disease (DKD) in terms of the pathological features, treatment strategy and prognosis. Although renal biopsy is the current gold-standard diagnostic method, it cannot be routinely performed due to a range of risks. The aim of this study was to explore the predictors for differentiating NDKD from DKD to meet the urgent medical needs of patients who cannot afford kidney biopsy. METHODS: This is a retrospective study conducted by reviewing the medical records of patients with type 2 DM who underwent percutaneous renal biopsy at the Affiliated Hospital of Guizhou Medical University between January 2017 and May 2021. The demographic data, clinical data, blood test results, and pathological examination results of the patients were obtained from their medical records. Multivariate regression analysis was performed to evaluate the predictive factors for NDKD. RESULTS: A total of 244 patients were analyzed. The median age at biopsy was 55 (46, 62) years. Patients diagnosed with true DKD, those diagnosed with NDKD and those diagnosed with NDKD superimposed DKD represented 48.36% (118/244), 45.9% (112/244) and 5.74% (14/244), respectively, of the patient population. Immunoglobulin A nephropathy was the most common type of lesion in those with NDKD (59, 52.68%) and NDKD superimposed DKD (10, 71.43%). Independent predictive indicators for diagnosing NDKD included a DM duration of less than 5 years (odds ratio [OR] = 4.476; 95% confidence interval [CI]: 2.257–8.877; P < 0.001), an absence of diabetic retinopathy (OR = 4.174; 95% CI: 2.049–8.502; P < 0.001), a high RBC count (OR = 1.901; 95% CI: 1.251–2.889; P = 0.003), and a negative of urinary glucose excretion test result (OR = 2.985; 95% CI: 1.474–6.044; P = 0.002).. CONCLUSIONS: A DM duration less than 5 years, an absence of retinopathy, a high RBC count and an absence of urinary glucose excretion were independent indicators for the diagnosis of NDKD, suggesting that patients with NDKD may require a different treatment regimen than those with DKD. |
format | Online Article Text |
id | pubmed-9248150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92481502022-07-02 Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 Zeng, Yong-qin Yang, Yu-xing Guan, Cheng-jing Guo, Zi-wei Li, Bo Yu, Hai-yan Chen, Rui-xue Tang, Ying-qian Yan, Rui BMC Endocr Disord Research BACKGROUND: Nondiabetic kidney disease (NDKD), which is prevalent among patients with diabetes mellitus (DM), is considerably different from diabetic kidney disease (DKD) in terms of the pathological features, treatment strategy and prognosis. Although renal biopsy is the current gold-standard diagnostic method, it cannot be routinely performed due to a range of risks. The aim of this study was to explore the predictors for differentiating NDKD from DKD to meet the urgent medical needs of patients who cannot afford kidney biopsy. METHODS: This is a retrospective study conducted by reviewing the medical records of patients with type 2 DM who underwent percutaneous renal biopsy at the Affiliated Hospital of Guizhou Medical University between January 2017 and May 2021. The demographic data, clinical data, blood test results, and pathological examination results of the patients were obtained from their medical records. Multivariate regression analysis was performed to evaluate the predictive factors for NDKD. RESULTS: A total of 244 patients were analyzed. The median age at biopsy was 55 (46, 62) years. Patients diagnosed with true DKD, those diagnosed with NDKD and those diagnosed with NDKD superimposed DKD represented 48.36% (118/244), 45.9% (112/244) and 5.74% (14/244), respectively, of the patient population. Immunoglobulin A nephropathy was the most common type of lesion in those with NDKD (59, 52.68%) and NDKD superimposed DKD (10, 71.43%). Independent predictive indicators for diagnosing NDKD included a DM duration of less than 5 years (odds ratio [OR] = 4.476; 95% confidence interval [CI]: 2.257–8.877; P < 0.001), an absence of diabetic retinopathy (OR = 4.174; 95% CI: 2.049–8.502; P < 0.001), a high RBC count (OR = 1.901; 95% CI: 1.251–2.889; P = 0.003), and a negative of urinary glucose excretion test result (OR = 2.985; 95% CI: 1.474–6.044; P = 0.002).. CONCLUSIONS: A DM duration less than 5 years, an absence of retinopathy, a high RBC count and an absence of urinary glucose excretion were independent indicators for the diagnosis of NDKD, suggesting that patients with NDKD may require a different treatment regimen than those with DKD. BioMed Central 2022-06-30 /pmc/articles/PMC9248150/ /pubmed/35773653 http://dx.doi.org/10.1186/s12902-022-01082-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zeng, Yong-qin Yang, Yu-xing Guan, Cheng-jing Guo, Zi-wei Li, Bo Yu, Hai-yan Chen, Rui-xue Tang, Ying-qian Yan, Rui Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title | Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title_full | Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title_fullStr | Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title_full_unstemmed | Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title_short | Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
title_sort | clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248150/ https://www.ncbi.nlm.nih.gov/pubmed/35773653 http://dx.doi.org/10.1186/s12902-022-01082-8 |
work_keys_str_mv | AT zengyongqin clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT yangyuxing clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT guanchengjing clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT guoziwei clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT libo clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT yuhaiyan clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT chenruixue clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT tangyingqian clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 AT yanrui clinicalpredictorsfornondiabetickidneydiseasesinpatientswithtype2diabetesmellitusaretrospectivestudyfrom2017to2021 |